Cart
sales@molnova.com
CCG-203971
CAS No. 1443437-74-8
CCG-203971( CCG-203971 | CCG 203971 )
Catalog No. M18020 CAS No. 1443437-74-8
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 92 | In Stock |
|
| 50MG | 137 | In Stock |
|
| 100MG | 220 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 545 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCCG-203971
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.
-
DescriptionCCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971 causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.
-
In Vitro——
-
In Vivo——
-
SynonymsCCG-203971 | CCG 203971
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
Recptorothers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1443437-74-8
-
Formula Weight408.88
-
Molecular FormulaC23H21ClN2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 155 mg/mL 379.08 mM; H2O : < 0.1 mg/mL
-
SMILESO=C(C1CN(C(C2=CC=CC(C3=CC=CO3)=C2)=O)CCC1)NC4=CC=C(Cl)C=C4
-
Chemical NameN-(4-chlorophenyl)-1-[3-(furan-2-yl)benzoyl]piperidine-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Methylbenactyzine Br...
Dimethadione is an anticonvulsant that is the active metabolite of trimethadione.
-
NSAH?
NSAH is a nonnucleoside inhibitor of human ribonucleotide reductase (hRR).with cell-free IC50 of 32 μM and cell-based IC50 of ~250 nM, respectively.A unique nonnucleoside small-molecule hRR inhibitor, naphthyl salicylic acyl hydrazone (NSAH), using virtual screening, binding affinity, inhibition, and cell toxicity assays.?NSAH binds to hRRM1 with an apparent dissociation constant of 37 μM, and steady-state kinetics reveal a competitive mode of inhibition.?
-
DMT-dU-CE Phosphoram...
DMT-dU-CE Phosphoramidite is a nucleoside molecule commonly used for the synthesis and sequencing of DNA.
